Skip to main content
. 2024 Jan 24;11:1331761. doi: 10.3389/fmed.2024.1331761

Table 2.

Results from univariate and multivariate analysis of the relationship between comorbidities and type of pain.

Neuropathic Nociceptive Univariate Multivariate
Age* 55.2 ± 8.6 52.9 ± 11.4 0.2
Duration of the disease* 10.2 ± 7.8 9.8 ± 6.7 0.9
Treatment with bDMARD (yes/no) (%) 29.6 19.0 0.2
mMASES* 2.5 ± 2.7 0.8 ± 1.4 0.001
BMI* 28.2 ± 5.3 26.6 ± 4.9 0.09
Leptin (ηg/mL)* 26.8 ± 21.6 14.2 ± 13.5 0.001 OR: 1.03(1.007–1.056); p < 0.01**
HADS-D* 7.6 ± 4.10 3.9 ± 3.4 0.001
HADS-A* 9.8 ± 3.7 5.8 ± 3.9 0.001
ISI* 14.5 ± 6.1 7.3 ± 4.9 0.001 OR: 1.19(1.09–1.297); p < 0.001**

HADS-D and HADS-A, Depression and Anxiety subscales of the Hospital Anxiety and Depression Scale respectively; ISI, Insomnia Severity Index. *Values in cells represent (mean ± SD). **Nagelkerke R2: 0:52.